홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Thionyl Chloride → HCID 178471775, 화합물

HRID 505308
인쇄

반응식

HRID 505308 반응식
[CH2:1]([N:3]([CH2:16][C@H:17]1[CH2:22][CH2:21][C@H:20]([CH2:23][C:24]([O:26][CH2:27][CH3:28])=[O:25])[CH2:19][CH2:18]1)[C:4]1[CH:9]=[CH:8][C:7]([C:10]([F:13])([F:12])[F:11])=[CH:6][C:5]=1[CH2:14]O)[CH3:2].S(Cl)(Cl)=O.[F:33][C:34]([F:53])([F:52])[C:35]1[CH:36]=[C:37]([C@H:45]2[O:49][C:48](=[O:50])[NH:47][C@H:46]2[CH3:51])[CH:38]=[C:39]([C:41]([F:44])([F:43])[F:42])[CH:40]=1.CC(C)([O-])C.[K+]>C1(C)C=CC=CC=1.N1C=CC=CC=1>[F:53][C:34]([F:33])([F:52])[C:35]1[CH:36]=[C:37]([C@H:45]2[O:49][C:48](=[O:50])[N:47]([CH2:14][C:5]3[CH:6]=[C:7]([C:10]([F:13])([F:12])[F:11])[CH:8]=[CH:9][C:4]=3[N:3]([CH2:16][C@H:17]3[CH2:18][CH2:19][C@H:20]([CH2:23][C:24]([O:26][CH2:27][CH3:28])=[O:25])[CH2:21][CH2:22]3)[CH2:1][CH3:2])[C@H:46]2[CH3:51])[CH:38]=[C:39]([C:41]([F:42])([F:43])[F:44])[CH:40]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 4

HCID 24386Thionyl ChlorideHCID 23583229(4S,5R)-5-(3,5-bis(trifluoromethyl)phenyl)-4-methyloxazolidin-2-one2회HCID 23665647Potassium tert-butoxideHCID 178471782HCID 178471782, 화합물

생성물 1

HCID 178471775HCID 178471775, 화합물

시약·촉매·용매 2

HCID 1049
Pyridine
용매
HCID 1140Toluene용매2회

실험 절차

A solution of ethyl [trans-4-({ethyl[2-(hydroxymethyl)-4-(trifluoromethyl)phenyl]amino}methyl)cyclohexyl]acetate (Step B; 60 mg; 0.149 mmol) in toluene (1 mL) was added dropwise to a stirred solution of thionyl chloride (12.3 μL; 0.169 mmol) in toluene (300 μL) at 0° C. The reaction stirred at room temperature for 1.5 h. Pyridine (27 mL) was added and the reaction was partitioned between toluene (10 mL) and H2O (10 mL). The aqueous layer was re-extracted with toluene (10 mL) and the combined organic layers were washed with brine (10 mL), dried (Na2SO4), filtered and concentrated in vacuo. The residue was dissolved in DMF (1 mL) and (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-1,3-oxazolidin-2-one (intermediate 17; 56 mg; 0.179 mmol) and potassium tert-butoxide (23.5 mg; 0.209 mmol) were added successively. The reaction stirred for 72 h and was quenched with sat. NH4Cl. The reaction was partitioned between sat. NH4Cl (10 mL) and EtOAc (10 mL). The aqueous layer was re-extracted with EtOAc (3×10 mL) and the combined organic layers were washed with brine (10 mL), dried (Na2SO4), filtered and concentrated in vacuo. The residue was purified by flash silica gel chromatography (0-20% EtOAc/hexanes gradient) and chiral HPLC (1.5% IPA/heptane; ChiralPak IA column) to afford ethyl (trans-4-{[[2-({(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-2-oxo-1,3-oxazolidin-3-yl}methyl)-4-(trifluoromethyl)phenyl](ethyl)amino]methyl}cyclohexyl)acetate as a clear glass. LCMS=697.3 (M+1)+. 1H NMR (CDCl3, 500 MHz): δ 7.92 (s, 1 H), 7.81 (s, 2 H), 7.65 (s, 1 H), 7.58 (d, J=8.4 Hz, 1H), 7.30-7.27 (m, 1 H), 5.78 (d, J=8.1 Hz, 1 H), 4.88 (d, J=16.5 Hz, 1 H), 4.74-4.69 (m, 1 H), 4.11 (q, J=7.1 Hz, 2 H), 3.17-3.10 (m, 2 H), 3.05-2.97 (m, 2 H), 2.15 (d, J=6.8 Hz, 2 H), 1.80-1.68 (m, 4 H), 1.66-1.50 (m, 1 H), 1.46-1.39 (m, 1 H), 1.25 (t, J=7.1 Hz, 3 H), 1.07 (t, J=7.0 Hz, 3 H), 1.03-0.85 (m, 4H), 0.71 (d, J=6.6 Hz, 3 H).

후처리

  1. customthe reaction was partitioned between toluene (10 mL) and H2O (10 mL)
  2. extractionThe aqueous layer was re-extracted with toluene (10 mL)
  3. washthe combined organic layers were washed with brine (10 mL)
  4. dry with materialdried (Na2SO4)
  5. filtrationfiltered
  6. concentrationconcentrated in vacuo
  7. dissolutionThe residue was dissolved in DMF (1 mL)
  8. stirringThe reaction stirred for 72 h
  9. customwas quenched with sat. NH4Cl
  10. customThe reaction was partitioned between sat. NH4Cl (10 mL) and EtOAc (10 mL)
  11. extractionThe aqueous layer was re-extracted with EtOAc (3×10 mL)
  12. washthe combined organic layers were washed with brine (10 mL)
  13. dry with materialdried (Na2SO4)
  14. filtrationfiltered
  15. concentrationconcentrated in vacuo
  16. customThe residue was purified by flash silica gel chromatography (0-20% EtOAc/hexanes gradient) and chiral HPLC (1.5% IPA/heptane; ChiralPak IA column)

출처 및 근거

ORD 기록
ord-684484a3cc824a80ab586916d7e58f05
출처 데이터셋
uspto-grants-2010_08
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07781426B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트